×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Impact of Human Factors on the Development of Combination Products
Session Chair(s)
Muriel Didier
Human Factors Group Head
Novartis, Switzerland
Impact of Human Factors on the Development of Combination Products
Speaker(s)
Panel Discussion
Chin-Wei Soo, DrSc
Genentech, A Member of the Roche Group, United States
Global Regulatory Head, PTR Devices and Combination Products
Panel Discussion
Lee Wood, MSc
MedHF, Switzerland
Co-Founder and CEO
Panel Discussion
Andrew Warrington
DayOneLab, Switzerland
Panel Discussion
Edward James Oakeley, PhD
Patient Advocate, Switzerland
Patient Advocate
Have an account?